COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y ETINILESTRADIOL
Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SANDRONE, CARLOS, ARIEL LARROSA POMI, JOSE, DANIEL SAKSON, JOSE, MARIO CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN |
| description | Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil cloruro de metileno.
A pharmaceutical composition that comprises drospirenone and ethynylestradiol with an improved dissolution rate. A method of preparation of a pharmaceutical formulation that comprises drospirenone and ethynylestradiol in order to improve its dissolution profile. Said formulation can be used to produce an anovulatory effect when administered correctly in humans. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2344356TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2344356TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2344356TT33</originalsourceid><addsrcrecordid>eNrjZHB19vcN8A_2dPb091NwcwzydXR2DQ3xdHZUCAx1VQBJBrn6ubgquAT5Bwd4Atn-fo4KkQquIZ5-nj6uwSFBji6e_j48DKxpiTnFqbxQmptB0c01xNlDN7UgPz61uCAxOTUvtSTeNdjI2MTE2NQsJMTYmBg1AMD4LO0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y ETINILESTRADIOL</title><source>esp@cenet</source><creator>SANDRONE, CARLOS, ARIEL ; LARROSA POMI, JOSE, DANIEL ; SAKSON, JOSE, MARIO ; CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN</creator><creatorcontrib>SANDRONE, CARLOS, ARIEL ; LARROSA POMI, JOSE, DANIEL ; SAKSON, JOSE, MARIO ; CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN</creatorcontrib><description>Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil cloruro de metileno.
A pharmaceutical composition that comprises drospirenone and ethynylestradiol with an improved dissolution rate. A method of preparation of a pharmaceutical formulation that comprises drospirenone and ethynylestradiol in order to improve its dissolution profile. Said formulation can be used to produce an anovulatory effect when administered correctly in humans.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100825&DB=EPODOC&CC=ES&NR=2344356T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100825&DB=EPODOC&CC=ES&NR=2344356T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SANDRONE, CARLOS, ARIEL</creatorcontrib><creatorcontrib>LARROSA POMI, JOSE, DANIEL</creatorcontrib><creatorcontrib>SAKSON, JOSE, MARIO</creatorcontrib><creatorcontrib>CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN</creatorcontrib><title>COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y ETINILESTRADIOL</title><description>Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil cloruro de metileno.
A pharmaceutical composition that comprises drospirenone and ethynylestradiol with an improved dissolution rate. A method of preparation of a pharmaceutical formulation that comprises drospirenone and ethynylestradiol in order to improve its dissolution profile. Said formulation can be used to produce an anovulatory effect when administered correctly in humans.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB19vcN8A_2dPb091NwcwzydXR2DQ3xdHZUCAx1VQBJBrn6ubgquAT5Bwd4Atn-fo4KkQquIZ5-nj6uwSFBji6e_j48DKxpiTnFqbxQmptB0c01xNlDN7UgPz61uCAxOTUvtSTeNdjI2MTE2NQsJMTYmBg1AMD4LO0</recordid><startdate>20100825</startdate><enddate>20100825</enddate><creator>SANDRONE, CARLOS, ARIEL</creator><creator>LARROSA POMI, JOSE, DANIEL</creator><creator>SAKSON, JOSE, MARIO</creator><creator>CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN</creator><scope>EVB</scope></search><sort><creationdate>20100825</creationdate><title>COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y ETINILESTRADIOL</title><author>SANDRONE, CARLOS, ARIEL ; LARROSA POMI, JOSE, DANIEL ; SAKSON, JOSE, MARIO ; CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2344356TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SANDRONE, CARLOS, ARIEL</creatorcontrib><creatorcontrib>LARROSA POMI, JOSE, DANIEL</creatorcontrib><creatorcontrib>SAKSON, JOSE, MARIO</creatorcontrib><creatorcontrib>CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SANDRONE, CARLOS, ARIEL</au><au>LARROSA POMI, JOSE, DANIEL</au><au>SAKSON, JOSE, MARIO</au><au>CAJARVILLE BASAISTEGUI, MARIA DEL CARMEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y ETINILESTRADIOL</title><date>2010-08-25</date><risdate>2010</risdate><abstract>Una composición farmacéutica que comprende drospirenona y etinilestradiol en forma amorfa, adsorbidos sobre un soporte sólido terapéuticamente inerte, en combinación con excipientes farmacéuticamente aceptables, caracterizada porque la composición comprende cantidades medibles del disolvente volátil cloruro de metileno.
A pharmaceutical composition that comprises drospirenone and ethynylestradiol with an improved dissolution rate. A method of preparation of a pharmaceutical formulation that comprises drospirenone and ethynylestradiol in order to improve its dissolution profile. Said formulation can be used to produce an anovulatory effect when administered correctly in humans.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2344356TT3 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOSICION FARMACEUTICA QUE COMPRENDE DROSPIRENONA Y ETINILESTRADIOL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T18%3A37%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SANDRONE,%20CARLOS,%20ARIEL&rft.date=2010-08-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2344356TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |